SCHEMBL240541

SCHEMBL240541

CCCCCCCCCCCCCCCC(=O)NCCC(N)=O

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FAAH O00519 8/20 0.65
DNM1 Q05193 2/20 0.61
CASP2 P42575 1/20 0.60
NAAA Q02083 1/20 0.56
CNR1 P21554 2/20 0.55
CNR2 P34972 2/20 0.55
SLC6A5 Q9Y345 2/20 0.55
HSP90AA1 P07900 1/20 0.53
MEN1 O00255 1/20 0.53
TP53 P04637 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C19 P33261 1/20 0.53
SOAT1 P35610 1/20 0.53
KMT2A Q03164 1/20 0.53
EPHX2 P34913 2/20 0.53
SELP P16109 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL236535 1.00 FAAH (0.65) FAAHDNM1CASP2NAAACNR1
SCHEMBL5050329 1.00 FAAH (0.65) FAAHDNM1CASP2NAAACNR1
SCHEMBL241202 1.00 FAAH (0.65) FAAHDNM1CASP2NAAACNR1
SCHEMBL241545 1.00 FAAH (0.65) FAAHDNM1CASP2NAAACNR1
SCHEMBL14812783 1.00 FAAH (0.65) FAAHDNM1CASP2NAAACNR1
SCHEMBL5983516 0.98 FAAH (0.61) FAAHDNM1CASP2NAAACNR1
SCHEMBL29033428 0.94 FAAH (0.67) FAAHDNM1CASP2NAAACNR1
Octadecanoic Acid Amide SCHEMBL11227047 0.94 FAAH (0.67) FAAHDNM1CASP2NAAACNR1
SCHEMBL24102296 0.92 CASP2 (0.71) FAAHDNM1CASP2NAAASLC6A5
SCHEMBL21587881 0.92 FAAH (0.68) FAAHDNM1CASP2NAAASLC6A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 751 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3448354-B1 POST-FOAMING MILD CLEANSING COMPOSITION PZ CUSSONS INT LTD (GB) 2025-07-16 EP claimed
WO-2022223736-A1 TRANSITION METAL OXIDE ADDUCTS FOR REGULATED GENERATION OF REACTIVE OXYGEN SPECIES AURENA LABORATORIES HOLDING AB (SE) 2022-10-27 WO claimed
US-20220000100-A1 WATER CONDITIONING AND DRIFT CONTROL COMPOSITIONS AND METHODS OF USE RHODIA OPERATIONS (FR) 2022-01-06 US claimed
US-20190133905-A1 PERSONAL CLEANSING COMPOSITION PZ CUSSONS (INTERNATIONAL) LTD (GB) 2019-05-09 US claimed
US-20190117527-A1 POST-FOAMING MILD CLEANSING COMPOSITION PZ CUSSONS (INTERNATIONAL) LTD (GB) 2019-04-25 US claimed
US-20190117528-A1 AEROSOL GEL COMPOSITION PZ CUSSONS (INTERNATIONAL) LTD (GB) 2019-04-25 US claimed
US-20190099342-A1 COOLING PRODUCT SYMRISE AG (DE) 2019-04-04 US claimed
WO-2019060664-A2 WATER CONDITIONING AND DRIFT CONTROL COMPOSITIONS AND METHODS OF USE RHODIA OPERATIONS (FR) 2019-03-28 WO claimed
US-20190090477-A1 WATER CONDITIONING AND DRIFT CONTROL COMPOSITIONS AND METHODS OF USE RHODIA OPERATIONS (FR) 2019-03-28 US claimed
US-20180200397-A1 Disinfectant Composition with Rapid Antiviral Efficacy KIMBERLY-CLARK WORLDWIDE, INC. 2018-07-19 US claimed
WO-2013041485-A2 CONDITIONING DYEING AGENT FOR KERATINOUS FIBRES HENKEL AG & CO. KGAA (DE) 2013-03-28 WO claimed
US-6616922-B2 For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user THE DIAL CORPORATION 2003-09-09 US claimed
US-20030022941-A1 For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user Henkel IP & Holding GmbH (DE) 2003-01-30 US claimed
EP-1045891-A4 NOVEL QUATERNARY AMMONIUM COMPOUNDS, COMPOSITIONS CONTAINING THEM, AND USES THEREOF GOLDSCHMIDT CHEMICAL CORP (US) 2003-01-22 EP claimed
WO-2002076207-A1 ANTIBACTERIAL COMPOSITIONS THE DIAL CORPORATION (US) 2002-10-03 WO claimed
US-6376455-B1 FABRIC SOFTENER, QUATERNARY FATTY ACID AMINO ALCOHOL ESTERS OF METHYLETHANOLISOPROPANOLAMINE (MEIPA) WITH FATTY ACIDS IN THE RATIO OF FROM 1:1.5 TO 1:2 WITH USE OF MONOFUNCTIONAL ALCOHOLS OR BIFUNCTIONAL ALCOHOLS. GOLDSCHMIDT REWO GMBH & CO. KG (DE) 2002-04-23 US claimed
US-6211139-B1 Polyester polyquaternary compounds, compositions containing them, and use thereof GOLDSCHMIDT CHEMICAL CORPORATION 2001-04-03 US claimed
EP-1045891-A1 NOVEL QUATERNARY AMMONIUM COMPOUNDS, COMPOSITIONS CONTAINING THEM, AND USES THEREOF Goldschmidt Chemical Corporation (US) 2000-10-25 EP claimed
WO-1999035223-A1 NOVEL QUATERNARY AMMONIUM COMPOUNDS, COMPOSITIONS CONTAINING THEM, AND USES THEREOF WITCO CORPORATION (US) 1999-07-15 WO claimed
WO-1999035120-A1 NOVEL QUATERNARY AMMONIUM COMPOUNDS, COMPOSITIONS CONTAINING THEM, AND USES THEREOF WITCO CORPORATION (US) 1999-07-15 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190133905-A1 PERSONAL CLEANSING COMPOSITION CUTA, WASHC5, POLR1C FAAH 261/4885DNM1 3573/4885CASP2 3194/4885
US-20190099342-A1 COOLING PRODUCT TRPA1, TRPV2, NISCH FAAH 53/4885DNM1 4365/4885CASP2 76/4885
US-20190117527-A1 POST-FOAMING MILD CLEANSING COMPOSITION CUTA, PHOSPHO1, ERCC1 FAAH 56/4885DNM1 2931/4885CASP2 3028/4885
US-20030022941-A1 For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user CUTA, CHIT1, CLSPN FAAH 70/4885DNM1 1621/4885CASP2 896/4885
US-20180200397-A1 Disinfectant Composition with Rapid Antiviral Efficacy EIF2AK2, APOBEC3A, APOBEC3C FAAH 473/4885DNM1 523/4885CASP2 1361/4885
US-20190117528-A1 AEROSOL GEL COMPOSITION CUTA, RAB5IF, S100P FAAH 49/4885DNM1 3177/4885CASP2 4529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.